• vcard
212.413.2855
  • Education
    • J.D., University of Pennsylvania School of Law
    • B.A., Cornell University

Patrick Doherty is a shareholder in the Firm’s Corporate and Transactional Department in New York. Patrick’s practice focuses on mergers and acquisitions, representing private equity firms and public and private companies in acquisitions, dispositions, leveraged buyouts, joint ventures, and venture capital and growth equity investments. He also has extensive experience representing project owners, developers and equity investors in the formation of complex real estate joint ventures. Patrick represents clients in industries including financial services, health care, consumer products, manufacturing, media and entertainment and real estate.

  • Represented a global regulated medical waste and secure information destruction services company in acquisitions and divestitures totaling more than $250 million
  • Represented a global movie theater company and its private equity sponsors in the $245 million acquisition of a regional US movie theater chain
  • Represented a digital security company in a $188 million sale to a private equity buyer
  • Represented a health care-focused private equity firm in its $55 million carve-out acquisition of the on-site medical equipment services business of a national health care manufacturer
  • Represented a global private equity firm in a $200 million take-private transaction involving a national fashion retailer
  • Represented a US private equity firm in its $500 million acquisition of a global drug and medical device clinical research organization
  • Represented a leading long-term care provider in its $400 million sale to a national REIT
  • Represented a leading private equity firm in portfolio company initial public offerings of $450 million and $175 million
  • Represented a private equity buyer in its $2 billion preferred equity investment in a leading US retail bank
  • Represented a global investment bank in its role as financial advisor to the board of directors of a leading US health care provider in its $6.3 billion sale to a private equity sponsor
  • Represented real property development companies and equity sponsors in joint ventures ranging from $20 million to $200 million
  • Represented venture capital funds and early stage companies in seed- and series-round investments ranging from $5 to $25 million